09 febrero 2017

Yondelis . La Fase II para Tratamiento de Meningiomas de Grado II - III que lleva a Cabo la EORTC ... ha sido Actualizada // Primary completion date 2017-07 (Anticipated) .

Imagen relacionadaClinical Trials Identifier : NCT02234050

Updated : 2017_02_06.



Descriptive Information :

Brief title :

Trabectedin for Recurrent Grade II/III Meningioma .




Resultado de imagen de meningiomaOfficial title :

Trabectedin for Recurrent Grade II or III Meningioma: a Randomized Phase II Study of the EORTC Brain Tumor Group

Brief summary:


The aim of this study is to collect data on activity, toxicity and quality of life of Trabectedin therapy in patients with recurrent high-grade Meningioma.




Recruitment Information :

Status Recruiting :

Start date : 2015-07 .


Primary completion date 2017-07 (Anticipated) .

Administrative Data :

Organization Name : European Organisation for Research and Treatment of Cancer - EORTC .